General Information of Drug (ID: DMN7Y9K)

Drug Name
Alpidem Drug Info
Synonyms
ALPIDEM; 82626-01-5; Ananxyl; Alpidemum [Latin]; UNII-I93SC245QZ; SL 80.0342-00; 2-(6-Chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl)-N,N-dipropylacetamide; 6-Chloro-2-(p-chlorophenyl)-N,N-dipropylimidazo(1,2-a)pyridine-3-acetamide; CHEMBL54349; I93SC245QZ; S-800342; NCGC00182850-01; 6-Chlor-2-(4-chlorphenyl)-N,N-dipropylimidazol(1,2-a)pyridin-3-acetamid; DSSTox_RID_83237; DSSTox_CID_28972; DSSTox_GSID_49046; Alpidemum; 6-Chloro-2-(4-chlorophenyl)-N,N-dipropyl-imidazo[1,2-a]pyridine-3-acetamide
Indication
Disease Entry ICD 11 Status REF
Anxiety disorder 6B00-6B0Z Approved [1]
Cross-matching ID
PubChem CID
54897
ChEBI ID
CHEBI:135649
CAS Number
CAS 82626-01-5
TTD Drug ID
DMN7Y9K

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Phenobarbital DMXZOCG Seizure disorder 8A6Z Approved [4]
Allopregnanolone DMNLHAC Depression 6A70-6A7Z Approved [5]
THIOCOLCHICOSIDE DMEPWYA Muscle spasm MB47.3 Approved [6]
Clonazepam DMTO13J Epilepsy 8A60-8A68 Approved [7]
Piperazine DMTY9LU Ascariasis 1F62 Approved [8]
Moxidectin DMYGHX5 Onchocerciasis 1F6A Approved [9]
DP-VPA DMGOXPQ Bipolar disorder 6A60 Approved [10]
Androsterone DMITJAK N. A. N. A. Phase 3 [5]
ZK-93423 DMFWMKZ Epileptic seizures 8A61-8A6Z Phase 3 [11]
Phentermine+topiramate DMVEHM4 Obesity 5B81 Phase 3 [12]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Targeting Translocator protein (TSPO)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Diazepam DM08E9O Epilepsy 8A60-8A68 Approved [13]
Flunitrazepam DMGR5Z3 Insomnia 7A00-7A0Z Approved [14]
Oxazepam DMXNZM4 Anxiety disorder 6B00-6B0Z Approved [15]
Midazolam DMXOELT Irritability MB24 Approved [16]
Temazepam DM02A65 Insomnia 7A00-7A0Z Approved [16]
Flumazenil DMPCG2L Benzodiazepine overdose PC91 Approved [17]
Alprazolam DMC7XDN Anxiety disorder 6B00-6B0Z Approved [14]
Clotiazepam DM59AZT Anxiety disorder 6B00-6B0Z Approved [18]
Quazepam DMY4D87 Insomnia 7A00-7A0Z Approved [16]
Eszopiclone DM8RZ9H Insomnia 7A00-7A0Z Approved [19]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Gamma-aminobutyric acid receptor (GAR) TTNJYV2 NOUNIPROTAC Inhibitor [2]
Translocator protein (TSPO) TTPTXIN TSPO_HUMAN Inhibitor [3]

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 Synthesis and binding affinity of 2-phenylimidazo[1,2-alpha]pyridine derivatives for both central and peripheral benzodiazepine receptors. A new se... J Med Chem. 1997 Sep 12;40(19):3109-18.
3 Anxiolytic-like effects of N,N-dialkyl-2-phenylindol-3-ylglyoxylamides by modulation of translocator protein promoting neurosteroid biosynthesis. J Med Chem. 2008 Sep 25;51(18):5798-806.
4 DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008 Jan;36(Database issue):D901-6.
5 Neurosteroid analogues. 11. Alternative ring system scaffolds: gamma-aminobutyric acid receptor modulation and anesthetic actions of benz[f]indenes. J Med Chem. 2006 Jul 27;49(15):4595-605.
6 3-demethoxy-3-glycosylaminothiocolchicines: Synthesis of a new class of putative muscle relaxant compounds. J Med Chem. 2006 Sep 7;49(18):5571-7.
7 Glutamate- and GABA-based CNS therapeutics. Curr Opin Pharmacol. 2006 Feb;6(1):7-17.
8 Cyclooctadepsipeptides--an anthelmintically active class of compounds exhibiting a novel mode of action. Int J Antimicrob Agents. 2003 Sep;22(3):318-31.
9 2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89.
10 DP-VPA D-Pharm. Curr Opin Investig Drugs. 2002 Jun;3(6):921-3.
11 Structural requirements for agonist actions at the benzodiazepine receptor: studies with analogues of 6-(benzyloxy)-4-(methoxymethyl)-beta-carbolin... J Med Chem. 1990 Mar;33(3):1062-9.
12 Anti-obesity drugs. Expert Opin Pharmacother. 2008 Jun;9(8):1339-50.
13 Translocator protein (18 kDa) mediates the pro-growth effects of diazepam on Ehrlich tumor cells in vivo. Eur J Pharmacol. 2010 Jan 25;626(2-3):131-8.
14 Comparison of five benzodiazepine-receptor agonists on buprenorphine-induced mu-opioid receptor regulation. J Pharmacol Sci. 2009 May;110(1):36-46.
15 Effects of the combination of metyrapone and oxazepam on cocaine and food self-administration in rats. Pharmacol Biochem Behav. 2008 Nov;91(1):181-9.
16 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
17 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2879).
18 Effects of benzodiazepines and non-benzodiazepine compounds on the GABA-induced response in frog isolated sensory neurones. Br J Pharmacol. 1989 Nov;98(3):735-40.
19 New hypnotics: perspectives from sleep physiology. Vertex. 2007 Jul-Aug;18(74):294-9.